A Study of ASP2215 in Combination With Induction and Consolidation Chemotherapy in Patients With Newly Diagnosed Acute Myeloid Leukemia.
Clinical trial NCT02310321 · COMPLETED
Trial details
- NCT number
- NCT02310321
- Sponsor
- Astellas Pharma Inc
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2015-02-26
- Primary completion
- 2021-08-25
- Enrollment
- 97
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.